proTAME
proTAME Basic information
- Product Name:
- proTAME
- Synonyms:
-
- proTAME
- pro-Tosyl-L-Arginine Methyl Ester
- 10,12-Dioxa-6,8-diazatetradec-6-enoic acid, 2-[[(4-methylphenyl)sulfonyl]amino]-9,13-dioxo-14-phenyl-7-[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]-, methyl ester, (2S)-
- (2S)-2-[[(4-methylphenyl)sulfonyl]amino]-9,13-dioxo-14-phenyl-7-[[[[(2-phenylacetyl)oxy]methoxy]carbonyl]amino]-10,12-dioxa-6,8-diazatetradec-6-enoicacid,methylester
- CAS:
- 1362911-19-0
- MF:
- C34H38N4O12S
- MW:
- 726.75
- Mol File:
- 1362911-19-0.mol
proTAME Chemical Properties
- Density
- 1.32±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: Soluble
- pka
- 7.05±0.46(Predicted)
- form
- Solid
- color
- White to off-white
proTAME Usage And Synthesis
Description
ProTAME is an inhibitor of both APC/CFzr and APC/CCdc20. Combinations of proTAME with topoisomerase inhibitors, etoposide and doxorubicin, significantly increase cell death in Multiple Myeloma (MM) cell lines and primary cells, particularly if TOPIIα levels are first increased through pre-treatment with ProTAME.
Uses
proTAME, a cell-permeable proagent form of TAME, is an anaphase promoting complex/cyclosome (APC/C) inhibitor. proTAME causes cell cycle arrest in metaphase[1][2].
References
[1] Lenka Radonova, et al. ProTAME Arrest in Mammalian Oocytes and Embryos Does Not Require Spindle Assembly Checkpoint Activity. Int J Mol Sci. 2019 Sep 13;20(18):4537. DOI:10.3390/ijms20184537
[2] Monika Raab, et al. Blocking Mitotic Exit of Ovarian Cancer Cells by Pharmaceutical Inhibition of the Anaphase-Promoting Complex Reduces Chromosomal Instability. Neoplasia. 2019 Apr;21(4):363-375. DOI:10.1016/j.neo.2019.01.007
proTAMESupplier
- Tel
- 17702719238 18971495150;
- sales@sun-shinechem.com
- Tel
- 021-65675885 18964387627
- info@efebio.com
- Tel
- 400-9205774
- sales@glpbio.cn
- Tel
- +1-781-999-5354; +17819995354
- marketing@targetmol.com
- Tel
- 86-571-88216897,88216896 13588875226
- sales@hzclap.com